Cardinal Health — Oct 30, 2025 release

Other segment profit increased 60% to $166 million in the first quarter, driven by growth across the three operating segments: at-Home Solutions (including the acquisition of Advanced Diabetes Supply), OptiFreight Logistics, and Nuclear and Precision Health Solutions. Cardinal Health Page 3 Fiscal year 2026 outlook 2 Cardinal Health is raising its guidance for non-GAAP diluted EPS attributable to Cardinal Health, Inc. to a range of $9.65 to $9.85 (+17% to +20% growth). This $0.35 increase from the prior range of $9.30 to $9.50 takes into account the company’s strong first quarter performance and expected contributions from the acquisition of Solaris Health, which the company anticipates completing in early November. The company is also raising its expectations for adjusted free cash flow to $3.0 billion to $3.5 billion, from a prior range of $2.75 billion to $3.25 billion. This updated guidance reflects increased expectations at the segment level: • Pharmaceutical and Specialty Solutions segment profit growth raised to 16% to 19%, from the prior range of 11% to 13% • Other segment profit growth raised to 29% to 31%, from the prior range of 25% to 27% The company is also updating the following assumptions for the fiscal year: • Interest and other expense of ~$325 million, from a prior outlook of ~$275 million, reflecting financing costs for the Solaris Health acquisition • Diluted weighted average shares outstanding of ~238 million, from a prior range of 238 million to 240 million • Capital expenditures of $600 million to $650 million, from a prior outlook of ~$600 million Recent highlights • Cardinal Health’s Sonexus Acces